Bioaffinity technologies announces award of therapeutic patents in china, mexico and australia

San antonio, texas--(business wire)-- #biaf--bioaffinity technologies, inc. (nasdaq: biaf; biafw) announced the people's republic of china awarded a certificate of patent to the company's wholly owned subsidiary oncoselect® for its patent “porphyrin compounds and compositions useful for treating cancer” that is directed to novel compounds in which porphyrins are conjugated to chemotherapeutics for selective delivery of cancer treatment.
BIAF Ratings Summary
BIAF Quant Ranking